Prognostic significance of nemo-like kinase (NLK) expression in patients with gallbladder cancer

Tumor Biology

Volumn 34, Issue 6, 2013, Pages 3995-4000

  Li, Maolan ^a   Zhang, Shenglai ^a   Wang, Zhiqiang ^b   Zhang, Bingtai ^c   Wu, Xiangsong ^a   Weng, Hao ^a   Ding, Qian ^a   Tan, Zhujun ^a   Zhang, Ning ^c   Mu, Jiasheng ^a   Yang, Jiahua ^a   Shu, Yijun ^a   Bao, Runfa ^a   Ding, Qichen ^a   Wu, Wenguang ^a   Cao, Yang ^a   Liu, Yingbin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Department of Geriatrics Shanghai Changning Center Hospital   (China)

^c SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Gallbladder cancer; Immunohistochemistry; Nemo like kinase

Indexed keywords

NEMO LIKE KINASE; NUCLEAR PROTEIN; THREONINE PROTEINASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BENIGN TUMOR; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GALLBLADDER CARCINOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PERINEURAL INVASION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

EID: 84891491476     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0988-4     Document Type: Article

References (22)

1. Wistuba II, Gazdar AF. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer. 2004;4:695-706.
2. Li M, Shen J, Wu X, Zhang B, Zhang R, Weng H, et al. Downregulated expression of hepatoma-derived growth factor (HDGF) reduces gallbladder cancer cell proliferation and invasion. Med Oncol. 2013;30:587. doi: 10.1007/s12032-013-0587-7.
3. Boutros C, Gary M, Baldwin K, Somasundar P. Gallbladder cancer: past, present and an uncertain future. Surg Oncol. 2012;21:e183-91.
4. Cargnello M, Roux PP. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev. 2011;75:50-83.
5. Obara Y, Nakahata N. The signaling pathway leading to extracellular signal-regulated kinase 5 (ERK5) activation via G-proteins and ERK5-dependent neurotrophic effects. Mol Pharmacol. 2010;77:10-6.
6. Mendes-Pereira AM, Lord CJ, Ashworth A. NLK is a novel therapeutic target for PTEN deficient tumour cells. PLoS One. 2012;7:e47249.
7. Li Z, Cui G, Wang J, Yu Z, Zhao L, Lv Z. Nemo-like Kinase (NLK) involves in neuronal apoptosis after traumatic brain injury. Cell Mol Neurobiol. 2012;32:381-9.
8. Ota S, Ishitani S, Shimizu N, Matsumoto K, Itoh M, Ishitani T. NLK positively regulates Wnt/β- catenin signalling by phosphorylating LEF1 in neural progenitor cells. EMBO J. 2012;31:1904-15.
9. Tan Z, Li M, Wu W, Zhang L, Ding Q, Wu X, et al. NLK is a key regulator of proliferation and migration in gallbladder carcinoma cells. Mol Cell Biochem. 2012;369:27-33.
10. Pinheiro C, Longatto-Filho A, Scapulatempo C, Ferreira L, Martins S, Pellerin L, et al. Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Virchows Archiv. 2008;452:139-46.
11. Quan Z, Gu J, Dong P, Lu J, Wu X, Wu W, et al. Reactive oxygen species-mediated endoplasmic reticulum stress and mitochondrial dysfunction contribute to cirsimaritin-induced apoptosis in human gallbladder carcinoma GBC-SD cells. Cancer Lett. 2010;295:252-9.
12. Srivastava K, Srivastava A, Sharma KL, Mittal B. Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. Mutat Res. 2011;728:67-79.
13. Ishitani T, Ishitani S. Nemo-like kinase, a multifaceted cell signaling regulator. Cell Signal. 2013;25:190-7.
14. Ishitani T. Context-dependent dual and opposite roles of nemo-like kinase in the Wnt/β-catenin signaling. Cell Cycle. 2012;11:1743-5.
15. Yasuda J, Yokoo H, Yamada T, Kitabayashi I, Sekiya T, Ichikawa H. Nemo-like kinase suppresses a wide range of transcription factors, including nuclear factor-kB. Cancer Sci. 2004;95:52-7.
16. Zanotti S, Canalis E. Nemo-like kinase inhibits osteoblastogenesis by suppressing bone morphogenetic protein and WNT canonical signaling. J Cell Biochem. 2012;113:449-56.
17. Ota R, Kotani T, Yamashita M. Possible involvement of nemo-like kinase 1 in Xenopus oocyte maturation as a kinase responsible for Pumilio1, Pumilio2, and CPEB phosphorylation. Biochemistry. 2011;50:5648-59.
18. Togi S, Ikeda O, Kamitani S, Nakasuji M, Sekine Y, Muromoto R, et al. Zipper-interacting protein kinase (ZIPK) modulates canonical Wnt/β-Catenin signaling through interaction with nemo-like Kinase and T cell factor 4 (NLK/TCF4). J Biol Chem. 2011;286:19170-7.
19. Yasuda J, Tsuchiya A, Yamada T, Sakamoto M, Sekiya T, Hirohashi S. Nemo-like kinase induces apoptosis in DLD-1 human colon cancer cells. Biochem Biophys Res Commun. 2003;308:227-33.
20. Emami KH, Brown LG, Pitts TE, Sun X, Vessella RL, Corey E. Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells. Prostate. 2009;69:1481-92.
21. Cui G, Li Z, Shao B, Zhao L, Zhou Y, Lu T, et al. Clinical and biological significance of Nemo-like kinase expression in glioma. J Clin Neurosci. 2011;18:271-5.
22. Jung KH, Kim JK, Noh JH, Eun JW, Bae HJ, Xie HJ, et al. Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma. J Cell Biochem. 2010;110:687-96.